Lacosamide Mylan

Lacosamide, the active ingredient in Lacosamide Mylan, is an anticonvulsant presented as an oral tablet for oral use. It is used to treat partial‑onset seizures in patients with epilepsy. GNH USA supplies Lacosamide Mylan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lacosamide is an anticonvulsant that acts on neuronal sodium channels to control seizure activity. - Partial‑onset seizures: reduces the frequency of seizure episodes in patients with focal epilepsy. - Focal seizures: provides adjunctive seizure control when other therapies are insufficient. - Epilepsy (adjunctive therapy): improves overall seizure management as part of combination treatment.

Lacosamide may cause a range of adverse reactions.

Common Side Effects: - Dizziness - Nausea - Fatigue - Headache

Serious or Rare Side Effects: - Cardiac arrhythmia (e.g., PR‑interval prolongation) - Severe skin reactions such as Stevens‑Johnson syndrome - Suicidal thoughts or behavior

Before initiating therapy, consider the following precautions. - Renal impairment: assess renal function and adjust dose if necessary. - Hepatic impairment: monitor liver enzymes and consider dose modification. - Cardiac conduction disorders: avoid in patients with known PR‑interval prolongation. - Concomitant CYP3A4 inhibitors or inducers: monitor for altered plasma levels. - Pregnancy: risk unknown; prescribe only if benefit outweighs potential risk. - Store at below 25°C: keep in the original packaging, protect from moisture.

Lacosamide can interact with several medicines; review patient medication lists.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole) - Strong CYP3A4 inducers (e.g., carbamazepine, phenytoin) - Other sodium‑channel blockers (e.g., lamotrigine, phenytoin)

Moderate Interactions (Monitor Closely):\n- Anticoagulants such as warfarin - Hormonal contraceptives - Alcohol consumption